Search results for: hospital

FDA Expands Label for Insulin Degludec; Adalimumab Biosimilar Moves Forward After Legal Battle

Michele B. Kaufman, PharmD, BCGP | April 18, 2018

The FDA has expanded the label for insulin degludec to include data on improved cardiovascular outcomes and deceased severe hypoglycemia…

Poor Sleep Quality During Menopause Tied to Increased Inflammation

Cheryl Platzman Weinstock | April 17, 2018

(Reuters Health)—Middle-aged women who get poor quality sleep have elevated levels of inflammatory markers, suggesting their risk for heart disease and other illnesses may be increased, U.S. researchers say. Based on sleep monitoring and blood tests of 295 women, most of whom were past menopause, researchers found those who had trouble falling asleep or who…

FDA to Review Abuse Deterrent Oxycodone Capsule & More

Michele B. Kaufman, PharmD, BCGP | April 11, 2018

The FDA will discuss a New Drug Application for Remoxy ER during an upcoming advisory committee meeting and recently approved tildrakizumab-asmn to treat adults with plaque psoriasis…

Prior Authorizations Hurt Patients & Practices

From the College | April 4, 2018

The ACR was part of a 16-member collaboration that created a set of 21 principles on prior authorization and utilization management, intended to ensure that patients receive timely and medically necessary care and medications and reduce the administrative burdens. More than 100 other healthcare organizations support those principles. Now, the AMA has released the results…

Reduced Serum Uric Acid Levels May Protect Against Renal Function Decline

Lara C. Pullen, PhD | April 2, 2018

New research examined the link between a reduction in serum uric acid (SUA) levels and the reduced risk of renal function decline in patients with gout. The findings suggest that aggressive serum acid-lowering approaches may be helpful in slowing the progression of renal disease…

Study Examines Why Patients Exceed Recommended Doses of Ibuprofen & NSAIDs

Michele B. Kaufman, PharmD, BCGP | April 2, 2018

A recent study examined how often patients exceed the dosing limits of nonsteroidal anti-inflammatory drugs and identified the characteristics of the patients most likely to exceed recommended doses…

Dermatology Patients on Corticosteroids May Not Receive Osteoporosis Screenings; Plus FDA Approves ZTLido

Michele B. Kaufman, PharmD, BCGP | March 28, 2018

A recent study found that dermatology patients taking long-term steroids are not always evaluated for steroid-induced osteoporosis…

Risankizumab Promising for Psoriasis; Plus Canada Approves Brodalumab

Michele B. Kaufman, PharmD, BCGP | March 21, 2018

Two Phase 3 clinical trials show that risankizumab is effective for achieving skin clearance in patients with psoriasis…

In Memoriam: Paul A. Bacon, MD

Gretchen Henkel | March 19, 2018

Paul A. Bacon, MD, professor emeritus of the University of Birmingham’s Department of Rheumatology, died on Jan. 5, 2018. The news of his passing saddened those who had the good fortune to know and collaborate with him. He was admired for his indefatigable dedication to measurement in rheumatic disease, especially vasculitis, as well as to…

Ethics Forum: What to Do When an Autoimmune Patient Needs a Transplant?

W. Blaine Lapin, MD, Jennifer L. Rammel, MD, MPH, & Andrea A. Ramirez, MD, MEd | March 19, 2018

Despite our best efforts and modern interventions, we still have patients in the intensive care unit with organ failure. Although renal failure can be mitigated by dialysis, patients with cardiac or respiratory failure secondary to active autoimmune disease raise difficult clinical and ethical issues. Two recent cases, both with organ failure, led us to examine…